On July 19, Coecion announced the crown of the crown of the crown, and the initial immunogenic data in the 3-17-year-old population, proved to be stable, good immunogenic, and after vaccination The effect is better than 18 years of age or older.
Now, the effectiveness of the minors in the new crown vaccine of the Chinese medicine group is also open!
The latest research results show thatThe Chinese Pharmaceutical Group China's China Biological Coronentian vaccine is safe and tolerated in all dosages at the age of 3-17. After inoculating the new crown of the new crown, it can initiate a strong immune response for new crown viruses.
In order to further assess the safety and immunogenicity used in the 3-17 people aged 3-17, the Chinese Biological Beijing Biological Products Research Institute has conducted a new coronary virus inactivated vaccine (Vero cells) in 3- Clinical Tests of Pradestriobi Characterization of Safety and Immunogenicity in 17 - year - old health population.
On September 15, the International Medical Journal "The Lancet Infectious Diseses officially published the Chinese Biological Beijing Biological Research Institute" Safety andimmunogenicity of An Inactivated Covid-19Vaccine, BBIBP -CORV, in People Younger Than 18years: a Randomised, Double-Blind, Controlled, Phase 1/2 Trial & Rdquo; research results.
This studyDepartment of Disease Control and Prevention, Shangqiu City, Henan Province, ChinaCarry out, using random, double-blind, controlled I / II clinical trials, inoculated according to 0, 28, 56 days. Health Subjects are divided into different ages and different dose groups.
Safety data shows that the main local adverse reactions are pain in the vaccination site, the 3-5-year-old group, 6-12 years old group, the proportion of the 13-17 years old is 4%, 9.1%, 7.9% respectively, the whole body adverse reactions are fever, The 3-5-year-old group, the 6-12-year-old group, the proportion of the 13-17-year-old group was 12.7%, 5.2%, 10.3%, respectively.
The severity of adverse reactions is mostly mild.
Immunogenic research data showed that the new coronavirus inactivated vaccine (Vero cells) was vaccinated according to the immunization programs of 0, 28, and 56, and the results showed that the 3 doses of the 23rd immunized immunohalmunine was as low as 28 days. 13-17, 6-12 years old, 3-5 years old, 3-5 years of subject target dose group of 3 doses of 3-day anti-new crown and antibody GMT are 199.1, 184.8, 199.1, respectively.
research shows,Low doses, medium dose and high dose groups in the whole process of 8 days, and the neutralizing antibody and IgG antibodies are 100%.
Low, medium and high-dose test vaccines are significantly elevated in 28 days after the whole process, and the GMT levels of antibodies and IgG antibodies are significantly increased; the dose group and high dose groups are from 28 days after the whole process, neutralizing antibodies and IgG antibodies The horizontal is higher than the low dose group.
Related news, local time September 9,The Ministry of Health of the Morocco officially approves the registration of China's Chinese Biological New Crown vaccine.
This is also a country that is the 10th approved Registered National Medicine Group Chinese Biological New Crown Vaccine. Previously, the vaccine has been obtained separately.UAE, Bahrain, China, Bolivia, Seychelles, Thailand, Turkmenistan, Malaysia, PeruWaiting for the registration.
Up to now, China National Pharmaceutical Group Biological crown new vaccine has been in 107 countries, regions and international organizations approved for emergency use or market access, vaccinated population covering 196 country, China is the first to use the emergency certification (EUL) by WHO and EU GMP certification of the new crown vaccine.